In the lungs, TMEM16A is expressed at low levels in airway epithelial cells and airway and pulmonary arterial smooth muscle cells, and is upregulated during inflammatory airway diseases such as asthma and cystic fibrosis (CF) [2,3,4,5]. Here, ANO1 is linked to cystic fibrosis.